U.S. Paper and Forestry Products Stock News

NYSE:ICE
NYSE:ICECapital Markets

Is Intercontinental Exchange (ICE) Fairly Priced Or Too Expensive Now?

Intercontinental Exchange stock has delivered a 35.4% gain over the past three years, yet the current checks send a mixed message as the Excess Returns intrinsic value estimate points to a roughly fair price while earnings based multiples lean expensive. Over the last three years, Intercontinental Exchange shares are up 35.4%, which puts recent weakness into context after a tougher past year. Planned expansion in fixed income trading and data, including the agreed MarketAxess acquisition and...
NYSE:IFF
NYSE:IFFChemicals

Why International Flavors & Fragrances (IFF) Is Up 6.4% After New $2.5 Billion Buyback And Guidance

International Flavors & Fragrances Inc. recently reported second-quarter 2026 results showing slightly higher sales of US$1,954 million but a sharp drop in net income to US$50 million, alongside updated full-year guidance reflecting discontinued operations. At the same time, the company unveiled a new US$2.50 billion share repurchase program and affirmed its regular quarterly dividend, underscoring management’s capital return priorities during its portfolio reshaping. We’ll now examine how...
NasdaqGS:PLUS
NasdaqGS:PLUSElectronic

Is ePlus (PLUS) Undervalued Following Strong Bookings And Reiterated 2027 Outlook?

ePlus (PLUS) drew investor attention after reporting modest revenue growth for the fiscal first quarter of 2027, highlighting higher bookings and open orders tied to demand for AI infrastructure, security, cloud, and managed services. See our latest analysis for ePlus. At a share price of $90.35, ePlus has seen short term share price momentum cool after the earnings release, with a 1 day share price return that declined 4.45%. However, the 1 month share price return of 7.78% and 1 year total...
NasdaqGM:ETON
NasdaqGM:ETONPharmaceuticals

Eton Pharmaceuticals (ETON) Stock Could Be Pricey On A Very Large Three Year Run

Eton Pharmaceuticals stock has delivered very strong long term gains for shareholders over the last three years, yet the current checks suggest the shares now lean expensive rather than obviously cheap. Eton Pharmaceuticals has returned about 16.8x over the last three years, which puts extra focus on whether the recent share price now runs ahead of business fundamentals. Expectations that Eton Pharmaceuticals can keep building its product revenues and cash flows may support the current...
NYSE:KRMN
NYSE:KRMNAerospace & Defense

Why Is Karman Holdings (KRMN) Refinancing Its Debt At Lower Rates?

Karman Holdings (NYSE:KRMN) has refinanced its term loans and revolving credit facility through a Fifth Amendment to its Credit Agreement. The amended facilities provide lower interest rates across key debt instruments compared with the prior terms. The refinancing is expected to influence Karman Holdings' future cost of capital, financial flexibility and long term planning. Readers looking for more ideas in companies where financing terms and profitability matter can continue their...
NYSE:LCII
NYSE:LCIIAuto Components

LCI Industries (LCII) As RV Pressure Tests An Undervalued Diversification Story

Guidance cut, earnings update and ESOP shelf filing reshape the LCI Industries story LCI Industries (LCII) has tightened its 2026 outlook, reported second quarter results and filed a new shelf registration, giving investors several fresh data points to assess the stock. See our latest analysis for LCI Industries. The LCI Industries share price is US$105.81, with the stock down about 11% over the past 90 days and about 15% year to date, while the 1 year total shareholder return is about 15%,...